We actively promote the transformational benefits of IP and its power to drive original thinking in the Life Sciences. We do this with our members, governments, intergovernmental bodies, NGOs and wider society and we work tirelessly to advocate for healthcare innovation around the world
The COVID-19 pandemic presented humanity with unprecedented challenges. Researchers and biopharmaceutical companies responded by developing and delivering COVID-19 vaccines and treatments in record time. The innovation response to COVID-19 has been a singular achievement, but we will not be done until every person who needs a vaccine can get one.
Use our quick contact form to get in touch .